139 related articles for article (PubMed ID: 32337366)
1. Role of Reactive Oxygen Species in the Cytotoxicity of Arsenic Trioxide and Pamidronate for Human Prostate Cancer Cells.
Doroshow JH; Gaur S
React Oxyg Species (Apex); 2020 Mar; 9(26):81-94. PubMed ID: 32337366
[TBL] [Abstract][Full Text] [Related]
2. Exogenous phosphotyrosine modulates epidermal growth factor receptor tyrosine phosphorylation.
Mishra S; Hamburger AW
Carcinogenesis; 1993 Feb; 14(2):269-73. PubMed ID: 7679612
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of nuclear factor-kappaB activation and protein tyrosine phosphorylation by a tyrosine phosphatase inhibitor, pervanadate, involves reactive oxygen species in silica-stimulated macrophages.
Kang JL; Pack IS; Lee HS; Castranova V
Toxicology; 2000 Oct; 151(1-3):81-9. PubMed ID: 11074303
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
5. Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells.
Gafar AA; Draz HM; Goldberg AA; Bashandy MA; Bakry S; Khalifa MA; AbuShair W; Titorenko VI; Sanderson JT
PeerJ; 2016; 4():e2445. PubMed ID: 27896021
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.
Kenner KA; Anyanwu E; Olefsky JM; Kusari J
J Biol Chem; 1996 Aug; 271(33):19810-6. PubMed ID: 8702689
[TBL] [Abstract][Full Text] [Related]
10. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase.
Way BA; Mooney RA
J Biol Chem; 1993 Dec; 268(35):26409-15. PubMed ID: 8253766
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells.
Chiu HW; Chen YA; Ho SY; Wang YJ
PLoS One; 2012; 7(2):e31579. PubMed ID: 22363680
[TBL] [Abstract][Full Text] [Related]
12. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
[TBL] [Abstract][Full Text] [Related]
13. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L
Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of phosphotyrosine phosphatase expression on hormone-dependent and independent pp60c-src activity.
Way BA; Mooney RA
Mol Cell Biochem; 1994 Oct; 139(2):167-75. PubMed ID: 7532275
[TBL] [Abstract][Full Text] [Related]
15. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes.
Fang Y; Han SI; Mitchell C; Gupta S; Studer E; Grant S; Hylemon PB; Dent P
Hepatology; 2004 Oct; 40(4):961-71. PubMed ID: 15382121
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.
Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
Fozing T; Scheuer C; Samnick S
Eur J Med Chem; 2010 Sep; 45(9):3780-6. PubMed ID: 20538380
[TBL] [Abstract][Full Text] [Related]
20. In vitro anti-prostate cancer and ex vivo antiangiogenic activity of Vernonia guineensis Benth. (Asteraceae) tuber extracts.
Toyang NJ; Wabo HK; Ateh EN; Davis H; Tane P; Kimbu SF; Sondengam LB; Bryant J
J Ethnopharmacol; 2012 Jun; 141(3):866-71. PubMed ID: 22465590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
